Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs

•We evaluated the effects of opioids on innate immune function in healthy dogs.•Opioids do not significantly affect leukocyte stimulated cytokine production.•Opioids do not significantly affect early leukocyte apoptosis or phagocytic function.•There is a potential association between hospital stress...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research in veterinary science 2015-04, Vol.99, p.70-76
Hauptverfasser: Monibi, Farrah A., Dodam, John R., Axiak-Bechtel, Sandra M., Amorim, Juliana, Zhang, Yan, Tsuruta, Kaoru, Mann, F.A., DeClue, Amy E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue
container_start_page 70
container_title Research in veterinary science
container_volume 99
creator Monibi, Farrah A.
Dodam, John R.
Axiak-Bechtel, Sandra M.
Amorim, Juliana
Zhang, Yan
Tsuruta, Kaoru
Mann, F.A.
DeClue, Amy E.
description •We evaluated the effects of opioids on innate immune function in healthy dogs.•Opioids do not significantly affect leukocyte stimulated cytokine production.•Opioids do not significantly affect early leukocyte apoptosis or phagocytic function.•There is a potential association between hospital stress and cytokine production.•Dogs could be less sensitive to immunomodulatory effects of acute opioid treatment. Opioids have immunomodulatory properties in many species, but there is little information pertaining to these properties in dogs. Our objective was to compare the in vivo effects of morphine, buprenorphine, and control solution on innate immune system function and apoptosis in healthy dogs. Six adult dogs received a 24-hour infusion of morphine, buprenorphine, or control solution (saline) in a randomized, controlled, crossover block design. Leukocyte apoptosis, phagocytosis, and oxidative burst were evaluated using flow cytometry. Lipopolysaccharide, lipoteichoic acid, and peptidoglycan-stimulated leukocyte production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 were determined using canine specific multiplex assays. No significant treatment effects were detected among groups. These data suggest that healthy dogs could be less sensitive to the immunomodulatory effects of acute opioid administration compared with other species. Larger investigations in healthy and immunologically challenged dogs are recommended prior to application of these results in clinical patients.
doi_str_mv 10.1016/j.rvsc.2015.01.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668268629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0034528815000351</els_id><sourcerecordid>1666296293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-f0768ea10416a6cc91d7b4bc9b19057c983fb1e781e83a71adfb04fb8dc9660c3</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EotPCC7BAltiwaAbbSRxHYoMqKJVadQNry7FvOp5m7OCfSnkNnriOpmXBAiFd2bL93XN1fBB6R8mWEso_7bfhIeotI7TdElqKvEAb2tasYpzTl2hDSN1ULRPiBJ3GuCeENJR2r9EJazkvB75Bv298mHfWAVbO4CHPAdzzjfHY-YTVlCDgCfK910sCXBZ_v77PwZusk_UOazUrbdNyjkGFacFq9nPy0cZz7AN2kFPwRXTC807drTJW4zG7Y7N1eAdlym4pI-_iG_RqVFOEt0_7Gfr57euPi-_V9e3l1cWX60o3okvVSDouQNHiiSuudU9NNzSD7gfak7bTvajHgUInKIhadVSZcSDNOAij--Je12fo41G3-PiVISZ5sFHDNCkHPkdJOReMC876_0ELtpIF_fAXuvc5uGJkpRpBWN-3hWJHSgcfY4BRzsEeVFgkJXINV-7lGq5cw5WEliKl6f2TdB4OYP60PKdZgM9HAMq3PVgIMmoLToOxAXSSxtt_6T8C06-4ug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664802995</pqid></control><display><type>article</type><title>Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Monibi, Farrah A. ; Dodam, John R. ; Axiak-Bechtel, Sandra M. ; Amorim, Juliana ; Zhang, Yan ; Tsuruta, Kaoru ; Mann, F.A. ; DeClue, Amy E.</creator><creatorcontrib>Monibi, Farrah A. ; Dodam, John R. ; Axiak-Bechtel, Sandra M. ; Amorim, Juliana ; Zhang, Yan ; Tsuruta, Kaoru ; Mann, F.A. ; DeClue, Amy E.</creatorcontrib><description>•We evaluated the effects of opioids on innate immune function in healthy dogs.•Opioids do not significantly affect leukocyte stimulated cytokine production.•Opioids do not significantly affect early leukocyte apoptosis or phagocytic function.•There is a potential association between hospital stress and cytokine production.•Dogs could be less sensitive to immunomodulatory effects of acute opioid treatment. Opioids have immunomodulatory properties in many species, but there is little information pertaining to these properties in dogs. Our objective was to compare the in vivo effects of morphine, buprenorphine, and control solution on innate immune system function and apoptosis in healthy dogs. Six adult dogs received a 24-hour infusion of morphine, buprenorphine, or control solution (saline) in a randomized, controlled, crossover block design. Leukocyte apoptosis, phagocytosis, and oxidative burst were evaluated using flow cytometry. Lipopolysaccharide, lipoteichoic acid, and peptidoglycan-stimulated leukocyte production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 were determined using canine specific multiplex assays. No significant treatment effects were detected among groups. These data suggest that healthy dogs could be less sensitive to the immunomodulatory effects of acute opioid administration compared with other species. Larger investigations in healthy and immunologically challenged dogs are recommended prior to application of these results in clinical patients.</description><identifier>ISSN: 0034-5288</identifier><identifier>EISSN: 1532-2661</identifier><identifier>DOI: 10.1016/j.rvsc.2015.01.010</identifier><identifier>PMID: 25660046</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Analgesics, Opioid - pharmacology ; Animals ; Apoptosis ; Apoptosis - drug effects ; Buprenorphine - pharmacology ; Colleges &amp; universities ; Cross-Over Studies ; Cytokine ; Cytokines - metabolism ; Disease ; Dogs ; Female ; Hypotheses ; Immune system ; Immunity, Innate - drug effects ; Immunity, Innate - physiology ; Immunology ; Innate immunity ; Interleukin-10 - metabolism ; Interleukin-6 - metabolism ; Laboratories ; Leukocytes - drug effects ; Leukocytes - metabolism ; Lipopolysaccharides - pharmacology ; Male ; Metabolites ; Morphine - pharmacology ; Neutrophils - drug effects ; Neutrophils - physiology ; Opioids ; Peptidoglycan - pharmacology ; Phagocytosis - drug effects ; Phagocytosis - physiology ; Teichoic Acids - pharmacology ; Tumor Necrosis Factor-alpha - metabolism ; Veterinary medicine</subject><ispartof>Research in veterinary science, 2015-04, Vol.99, p.70-76</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Limited Apr 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-f0768ea10416a6cc91d7b4bc9b19057c983fb1e781e83a71adfb04fb8dc9660c3</citedby><cites>FETCH-LOGICAL-c487t-f0768ea10416a6cc91d7b4bc9b19057c983fb1e781e83a71adfb04fb8dc9660c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rvsc.2015.01.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25660046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monibi, Farrah A.</creatorcontrib><creatorcontrib>Dodam, John R.</creatorcontrib><creatorcontrib>Axiak-Bechtel, Sandra M.</creatorcontrib><creatorcontrib>Amorim, Juliana</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Tsuruta, Kaoru</creatorcontrib><creatorcontrib>Mann, F.A.</creatorcontrib><creatorcontrib>DeClue, Amy E.</creatorcontrib><title>Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs</title><title>Research in veterinary science</title><addtitle>Res Vet Sci</addtitle><description>•We evaluated the effects of opioids on innate immune function in healthy dogs.•Opioids do not significantly affect leukocyte stimulated cytokine production.•Opioids do not significantly affect early leukocyte apoptosis or phagocytic function.•There is a potential association between hospital stress and cytokine production.•Dogs could be less sensitive to immunomodulatory effects of acute opioid treatment. Opioids have immunomodulatory properties in many species, but there is little information pertaining to these properties in dogs. Our objective was to compare the in vivo effects of morphine, buprenorphine, and control solution on innate immune system function and apoptosis in healthy dogs. Six adult dogs received a 24-hour infusion of morphine, buprenorphine, or control solution (saline) in a randomized, controlled, crossover block design. Leukocyte apoptosis, phagocytosis, and oxidative burst were evaluated using flow cytometry. Lipopolysaccharide, lipoteichoic acid, and peptidoglycan-stimulated leukocyte production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 were determined using canine specific multiplex assays. No significant treatment effects were detected among groups. These data suggest that healthy dogs could be less sensitive to the immunomodulatory effects of acute opioid administration compared with other species. Larger investigations in healthy and immunologically challenged dogs are recommended prior to application of these results in clinical patients.</description><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Buprenorphine - pharmacology</subject><subject>Colleges &amp; universities</subject><subject>Cross-Over Studies</subject><subject>Cytokine</subject><subject>Cytokines - metabolism</subject><subject>Disease</subject><subject>Dogs</subject><subject>Female</subject><subject>Hypotheses</subject><subject>Immune system</subject><subject>Immunity, Innate - drug effects</subject><subject>Immunity, Innate - physiology</subject><subject>Immunology</subject><subject>Innate immunity</subject><subject>Interleukin-10 - metabolism</subject><subject>Interleukin-6 - metabolism</subject><subject>Laboratories</subject><subject>Leukocytes - drug effects</subject><subject>Leukocytes - metabolism</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Male</subject><subject>Metabolites</subject><subject>Morphine - pharmacology</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - physiology</subject><subject>Opioids</subject><subject>Peptidoglycan - pharmacology</subject><subject>Phagocytosis - drug effects</subject><subject>Phagocytosis - physiology</subject><subject>Teichoic Acids - pharmacology</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Veterinary medicine</subject><issn>0034-5288</issn><issn>1532-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS0EotPCC7BAltiwaAbbSRxHYoMqKJVadQNry7FvOp5m7OCfSnkNnriOpmXBAiFd2bL93XN1fBB6R8mWEso_7bfhIeotI7TdElqKvEAb2tasYpzTl2hDSN1ULRPiBJ3GuCeENJR2r9EJazkvB75Bv298mHfWAVbO4CHPAdzzjfHY-YTVlCDgCfK910sCXBZ_v77PwZusk_UOazUrbdNyjkGFacFq9nPy0cZz7AN2kFPwRXTC807drTJW4zG7Y7N1eAdlym4pI-_iG_RqVFOEt0_7Gfr57euPi-_V9e3l1cWX60o3okvVSDouQNHiiSuudU9NNzSD7gfak7bTvajHgUInKIhadVSZcSDNOAij--Je12fo41G3-PiVISZ5sFHDNCkHPkdJOReMC876_0ELtpIF_fAXuvc5uGJkpRpBWN-3hWJHSgcfY4BRzsEeVFgkJXINV-7lGq5cw5WEliKl6f2TdB4OYP60PKdZgM9HAMq3PVgIMmoLToOxAXSSxtt_6T8C06-4ug</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Monibi, Farrah A.</creator><creator>Dodam, John R.</creator><creator>Axiak-Bechtel, Sandra M.</creator><creator>Amorim, Juliana</creator><creator>Zhang, Yan</creator><creator>Tsuruta, Kaoru</creator><creator>Mann, F.A.</creator><creator>DeClue, Amy E.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs</title><author>Monibi, Farrah A. ; Dodam, John R. ; Axiak-Bechtel, Sandra M. ; Amorim, Juliana ; Zhang, Yan ; Tsuruta, Kaoru ; Mann, F.A. ; DeClue, Amy E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-f0768ea10416a6cc91d7b4bc9b19057c983fb1e781e83a71adfb04fb8dc9660c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Buprenorphine - pharmacology</topic><topic>Colleges &amp; universities</topic><topic>Cross-Over Studies</topic><topic>Cytokine</topic><topic>Cytokines - metabolism</topic><topic>Disease</topic><topic>Dogs</topic><topic>Female</topic><topic>Hypotheses</topic><topic>Immune system</topic><topic>Immunity, Innate - drug effects</topic><topic>Immunity, Innate - physiology</topic><topic>Immunology</topic><topic>Innate immunity</topic><topic>Interleukin-10 - metabolism</topic><topic>Interleukin-6 - metabolism</topic><topic>Laboratories</topic><topic>Leukocytes - drug effects</topic><topic>Leukocytes - metabolism</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Male</topic><topic>Metabolites</topic><topic>Morphine - pharmacology</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - physiology</topic><topic>Opioids</topic><topic>Peptidoglycan - pharmacology</topic><topic>Phagocytosis - drug effects</topic><topic>Phagocytosis - physiology</topic><topic>Teichoic Acids - pharmacology</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monibi, Farrah A.</creatorcontrib><creatorcontrib>Dodam, John R.</creatorcontrib><creatorcontrib>Axiak-Bechtel, Sandra M.</creatorcontrib><creatorcontrib>Amorim, Juliana</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Tsuruta, Kaoru</creatorcontrib><creatorcontrib>Mann, F.A.</creatorcontrib><creatorcontrib>DeClue, Amy E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Research in veterinary science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monibi, Farrah A.</au><au>Dodam, John R.</au><au>Axiak-Bechtel, Sandra M.</au><au>Amorim, Juliana</au><au>Zhang, Yan</au><au>Tsuruta, Kaoru</au><au>Mann, F.A.</au><au>DeClue, Amy E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs</atitle><jtitle>Research in veterinary science</jtitle><addtitle>Res Vet Sci</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>99</volume><spage>70</spage><epage>76</epage><pages>70-76</pages><issn>0034-5288</issn><eissn>1532-2661</eissn><abstract>•We evaluated the effects of opioids on innate immune function in healthy dogs.•Opioids do not significantly affect leukocyte stimulated cytokine production.•Opioids do not significantly affect early leukocyte apoptosis or phagocytic function.•There is a potential association between hospital stress and cytokine production.•Dogs could be less sensitive to immunomodulatory effects of acute opioid treatment. Opioids have immunomodulatory properties in many species, but there is little information pertaining to these properties in dogs. Our objective was to compare the in vivo effects of morphine, buprenorphine, and control solution on innate immune system function and apoptosis in healthy dogs. Six adult dogs received a 24-hour infusion of morphine, buprenorphine, or control solution (saline) in a randomized, controlled, crossover block design. Leukocyte apoptosis, phagocytosis, and oxidative burst were evaluated using flow cytometry. Lipopolysaccharide, lipoteichoic acid, and peptidoglycan-stimulated leukocyte production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 were determined using canine specific multiplex assays. No significant treatment effects were detected among groups. These data suggest that healthy dogs could be less sensitive to the immunomodulatory effects of acute opioid administration compared with other species. Larger investigations in healthy and immunologically challenged dogs are recommended prior to application of these results in clinical patients.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25660046</pmid><doi>10.1016/j.rvsc.2015.01.010</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0034-5288
ispartof Research in veterinary science, 2015-04, Vol.99, p.70-76
issn 0034-5288
1532-2661
language eng
recordid cdi_proquest_miscellaneous_1668268629
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Analgesics, Opioid - pharmacology
Animals
Apoptosis
Apoptosis - drug effects
Buprenorphine - pharmacology
Colleges & universities
Cross-Over Studies
Cytokine
Cytokines - metabolism
Disease
Dogs
Female
Hypotheses
Immune system
Immunity, Innate - drug effects
Immunity, Innate - physiology
Immunology
Innate immunity
Interleukin-10 - metabolism
Interleukin-6 - metabolism
Laboratories
Leukocytes - drug effects
Leukocytes - metabolism
Lipopolysaccharides - pharmacology
Male
Metabolites
Morphine - pharmacology
Neutrophils - drug effects
Neutrophils - physiology
Opioids
Peptidoglycan - pharmacology
Phagocytosis - drug effects
Phagocytosis - physiology
Teichoic Acids - pharmacology
Tumor Necrosis Factor-alpha - metabolism
Veterinary medicine
title Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morphine%20and%20buprenorphine%20do%20not%20alter%20leukocyte%20cytokine%20production%20capacity,%20early%20apoptosis,%20or%20neutrophil%20phagocytic%20function%20in%20healthy%20dogs&rft.jtitle=Research%20in%20veterinary%20science&rft.au=Monibi,%20Farrah%20A.&rft.date=2015-04-01&rft.volume=99&rft.spage=70&rft.epage=76&rft.pages=70-76&rft.issn=0034-5288&rft.eissn=1532-2661&rft_id=info:doi/10.1016/j.rvsc.2015.01.010&rft_dat=%3Cproquest_cross%3E1666296293%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1664802995&rft_id=info:pmid/25660046&rft_els_id=S0034528815000351&rfr_iscdi=true